These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 3028427)

  • 1. Antiviral activity of 2',3'-dideoxycytidin-2'-ene (2',3'-dideoxy-2',3'-didehydrocytidine) against human immunodeficiency virus in vitro.
    Lin TS; Schinazi RF; Chen MS; Kinney-Thomas E; Prusoff WH
    Biochem Pharmacol; 1987 Feb; 36(3):311-6. PubMed ID: 3028427
    [No Abstract]   [Full Text] [Related]  

  • 2. Potent and selective in vitro activity of 3'-deoxythymidin-2'-ene (3'-deoxy-2',3'-didehydrothymidine) against human immunodeficiency virus.
    Lin TS; Schinazi RF; Prusoff WH
    Biochem Pharmacol; 1987 Sep; 36(17):2713-8. PubMed ID: 2443141
    [No Abstract]   [Full Text] [Related]  

  • 3. Sensitive and rapid assay on MT-4 cells for detection of antiviral compounds against the AIDS virus.
    Pauwels R; De Clercq E; Desmyter J; Balzarini J; Goubau P; Herdewijn P; Vanderhaeghe H; Vandeputte M
    J Virol Methods; 1987 Jun; 16(3):171-85. PubMed ID: 2821048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergistic interaction of 2',3'-dideoxycytidine and recombinant interferon-alpha-A on replication of human immunodeficiency virus type 1.
    Vogt MW; Durno AG; Chou TC; Coleman LA; Paradis TJ; Schooley RT; Kaplan JC; Hirsch MS
    J Infect Dis; 1988 Aug; 158(2):378-85. PubMed ID: 2841378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of infectivity and replication of HIV-2 and SIV in helper T-cells by 2',3'-dideoxynucleosides in vitro.
    Mitsuya H; Broder S
    AIDS Res Hum Retroviruses; 1988 Apr; 4(2):107-13. PubMed ID: 2835072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The in vitro and in vivo anti-retrovirus activity, and intracellular metabolism of 3'-azido-2',3'-dideoxythymidine and 2',3'-dideoxycytidine are highly dependent on the cell species.
    Balzarini J; Pauwels R; Baba M; Herdewijn P; de Clercq E; Broder S; Johns DG
    Biochem Pharmacol; 1988 Mar; 37(5):897-903. PubMed ID: 2830886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Zidovudin (Retrovir). A new antiviral agents against human immunodeficiency viruses (HIV)].
    Petersen CS; Ersbøll J; Mathiesen L; Krebs HJ
    Ugeskr Laeger; 1988 Jan; 150(4):247-8. PubMed ID: 3163864
    [No Abstract]   [Full Text] [Related]  

  • 8. Anti-retrovirus activity of 3'-fluoro- and 3'-azido-substituted pyrimidine 2',3'-dideoxynucleoside analogues.
    Balzarini J; Baba M; Pauwels R; Herdewijn P; De Clerq E
    Biochem Pharmacol; 1988 Jul; 37(14):2847-56. PubMed ID: 2840080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spectrum of antiviral activity and mechanism of action of zidovudine. An overview.
    Furman PA; Barry DW
    Am J Med; 1988 Aug; 85(2A):176-81. PubMed ID: 3044082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Azidothymidine and HIV infection].
    Offerhaus L
    Ned Tijdschr Geneeskd; 1987 May; 131(22):934-6. PubMed ID: 3037393
    [No Abstract]   [Full Text] [Related]  

  • 11. Dideoxynucleosides are less inhibitory in vitro against human immunodeficiency virus type 2 (HIV-2) than against HIV-1.
    Richman DD
    Antimicrob Agents Chemother; 1987 Dec; 31(12):1879-81. PubMed ID: 3501941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mismatched double-stranded RNA (ampligen) reduces concentration of zidovudine (azidothymidine) required for in-vitro inhibition of human immunodeficiency virus.
    Mitchell WM; Montefiori DC; Robinson WE; Strayer DR; Carter WA
    Lancet; 1987 Apr; 1(8538):890-2. PubMed ID: 2882293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 2',3'-Dideoxycytidine: regulation of its metabolism and anti-retroviral potency by natural pyrimidine nucleosides and by inhibitors of pyrimidine nucleotide synthesis.
    Balzarini J; Cooney DA; Dalal M; Kang GJ; Cupp JE; DeClercq E; Broder S; Johns DG
    Mol Pharmacol; 1987 Dec; 32(6):798-806. PubMed ID: 2826994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Failure of dideoxynucleosides to inhibit human immunodeficiency virus replication in cultured human macrophages.
    Richman DD; Kornbluth RS; Carson DA
    J Exp Med; 1987 Oct; 166(4):1144-9. PubMed ID: 2821152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-HIV synergism between dextran sulphate and zidovudine.
    Ueno R; Kuno S
    Lancet; 1987 Oct; 2(8562):796-7. PubMed ID: 2443775
    [No Abstract]   [Full Text] [Related]  

  • 16. Inhibition of the in vitro infectivity and cytopathic effect of human T-lymphotrophic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV) by 2',3'-dideoxynucleosides.
    Mitsuya H; Broder S
    Proc Natl Acad Sci U S A; 1986 Mar; 83(6):1911-5. PubMed ID: 3006077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Strategies for antiviral therapy in AIDS.
    Mitsuya H; Broder S
    Nature; 1987 Feb 26-Mar 4; 325(6107):773-8. PubMed ID: 2434858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergistic inhibition of human immunodeficiency virus in vitro by azidothymidine and recombinant alpha A interferon.
    Hartshorn KL; Vogt MW; Chou TC; Blumberg RS; Byington R; Schooley RT; Hirsch MS
    Antimicrob Agents Chemother; 1987 Feb; 31(2):168-72. PubMed ID: 3471180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 5-Halogeno-3'-fluoro-2',3'-dideoxyuridines as inhibitors of human immunodeficiency virus (HIV): potent and selective anti-HIV activity of 3'-fluoro-2',3'-dideoxy-5-chlorouridine.
    Balzarini J; Van Aerschot A; Pauwels R; Baba M; Schols D; Herdewijn P; De Clercq E
    Mol Pharmacol; 1989 May; 35(5):571-7. PubMed ID: 2725468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progress in antiviral drug and vaccine development assessed at international AIDS conference.
    Miller JL
    Clin Pharm; 1987 Aug; 6(8):592,595-6. PubMed ID: 2826072
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.